Researcher.Life Logo

Biomedical Materials (Bristol) : Impact Factor & More

eISSN: 1748-605XpISSN: 1748-6041

Key Metrics

CiteScore
5.5
H-Index
82
Impact Factor
< 5
SJR
Q2Biomaterials
SNIP
0.78
Recommended pre-submission checks
Powered by Paperpal by Editage

Biomedical Materials (Bristol) Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • Inspec Inspec
  • SJR SJR
Overview
Publisher IOP PUBLISHING LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Biomedical Materials (Bristol) ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Biomedical Materials (Bristol)

Decellularized matrix of porcine skeletal muscle (dECM-pSM) and itsin vitrobiocompatibility as a graft approach for oral mucosa regeneration.
  • 24 Apr 2026
  • Biomedical materials (Bristol, England)
A tunable, biofabricated light-delivery platform for in vitro modelling of age-related macular degeneration using iPSC-derived RPE cells.
  • 24 Apr 2026
  • Biomedical materials (Bristol, England)
A CREKA-modified multifunctional nanoplatform for targeted thrombolysis: anin vitrocharacterization of efficacy and biocompatibility for retinal thrombotic diseases.
  • 24 Apr 2026
  • Biomedical materials (Bristol, England)
Application of hybrid exosomes-mediated targeted delivery system for sinomenine hydrochloride in rheumatoid arthritis therapy.
  • 22 Apr 2026
  • Biomedical materials (Bristol, England)
Extracellular matrix-targeted biomaterials and nanocarriers for pelvic-floor repair/regeneration in stress urinary incontinence: local modulation of the MMP/TIMP axis and NF-κB/MAPK-linked remodeling programs.
  • 21 Apr 2026
  • Biomedical materials (Bristol, England)
Development and initial characterization of Ang-2 decorated exosome-liposome hybrid nanocarriers for BBB targeting capability: An evaluation of LRP-1 receptor mediated endocytosis.
  • 17 Apr 2026
  • Biomedical materials (Bristol, England)
Decellularized matrix of porcine skeletal muscle (dECM-pSM) and itsin vitrobiocompatibility as a graft approach for oral mucosa regeneration.
  • 24 Apr 2026
  • Biomedical materials (Bristol, England)
A tunable, biofabricated light-delivery platform for in vitro modelling of age-related macular degeneration using iPSC-derived RPE cells.
  • 24 Apr 2026
  • Biomedical materials (Bristol, England)
A CREKA-modified multifunctional nanoplatform for targeted thrombolysis: anin vitrocharacterization of efficacy and biocompatibility for retinal thrombotic diseases.
  • 24 Apr 2026
  • Biomedical materials (Bristol, England)
Application of hybrid exosomes-mediated targeted delivery system for sinomenine hydrochloride in rheumatoid arthritis therapy.
  • 22 Apr 2026
  • Biomedical materials (Bristol, England)
Extracellular matrix-targeted biomaterials and nanocarriers for pelvic-floor repair/regeneration in stress urinary incontinence: local modulation of the MMP/TIMP axis and NF-κB/MAPK-linked remodeling programs.
  • 21 Apr 2026
  • Biomedical materials (Bristol, England)
Development and initial characterization of Ang-2 decorated exosome-liposome hybrid nanocarriers for BBB targeting capability: An evaluation of LRP-1 receptor mediated endocytosis.
  • 17 Apr 2026
  • Biomedical materials (Bristol, England)

FAQs on Biomedical Materials (Bristol)